Curetoday.comNew Treatment Shows Promise in LymphomaCuretoday.comResearcher found that CD30-specific chimeric antigen receptor (CAR) T cells are a safe and durable treatment option to induce durable complete repsonses in patients who have Hodgkin lymph… Continue reading
|
Neue Techniken in alten Pflanzen
neues deutschland Wissenschaftler versprechen sich aufgrund der geringeren Größe des CRISPR/Cpf1-Systems eine flexiblere Nutzung an verschiedenen Kulturen. Einen anderen Ansatz stellt die Exzact-Technologie dar. Diesem in Zusammenarbeit der Unternehmen Dow … |
|
A virtuous CRISPR cycle
Nature.com Bacterial type II CRISPR–Cas systems are well suited for genome engineering because they target double-stranded DNA using a single effector nuclease, Cas9. In contrast, type III CRISPR–Cas systems have nuclease activities that target both DNA and RNA, … |
Futurism |
CRISPR Co-Discoverer: “I’ve Never Seen Science Move at the Pace It’s Moving Now”
Futurism The CRISPR gene editing tool has already been used to perform some incredible feats of science, from manipulating the social behavior of ants to making superbugs kill themselves. It’s an incredibly powerful asset, but this week at CrisprCon, there was … Monsanto, ToolGen enter Crispr licensing pactWorld Grain |
Drug Discovery & Development |
Scientists Develop Novel Immunotherapy Technology for Prostate Cancer
Drug Discovery & Development A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein. This is the first … |